192 related articles for article (PubMed ID: 17764571)
21. Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.
Kaasinen V; Kankare T; Joutsa J; Vahlberg T
J Nucl Med; 2019 Dec; 60(12):1757-1763. PubMed ID: 30979821
[TBL] [Abstract][Full Text] [Related]
22. Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.
Geibl FF; Henrich MT; Oertel WH
J Neural Transm (Vienna); 2019 Apr; 126(4):377-396. PubMed ID: 30643975
[TBL] [Abstract][Full Text] [Related]
23. Multivariate Analysis of
Segovia F; Górriz JM; Ramírez J; Martínez-Murcia FJ; Levin J; Schuberth M; Brendel M; Rominger A; Bötzel K; Garraux G; Phillips C
Front Neuroinform; 2017; 11():23. PubMed ID: 28424607
[TBL] [Abstract][Full Text] [Related]
24. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.
Saeed U; Compagnone J; Aviv RI; Strafella AP; Black SE; Lang AE; Masellis M
Transl Neurodegener; 2017; 6():8. PubMed ID: 28360997
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
26. Molecular imaging of movement disorders.
Lizarraga KJ; Gorgulho A; Chen W; De Salles AA
World J Radiol; 2016 Mar; 8(3):226-39. PubMed ID: 27029029
[TBL] [Abstract][Full Text] [Related]
27. Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging.
Covington MF; Sherman S; Lewis D; Lei H; Krupinski E; Kuo PH
PLoS One; 2015; 10(7):e0134457. PubMed ID: 26226362
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.
Suwijn SR; van Boheemen CJ; de Haan RJ; Tissingh G; Booij J; de Bie RM
EJNMMI Res; 2015; 5():12. PubMed ID: 25853018
[TBL] [Abstract][Full Text] [Related]
30. Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson's disease and essential tremor.
Štenc Bradvica I; Mihaljević I; Butković-Soldo S; Kadojić D; Titlić M; Bradvica M; Kralik K
Neurol Sci; 2015 Aug; 36(8):1403-10. PubMed ID: 25787809
[TBL] [Abstract][Full Text] [Related]
31. Neuroimaging in Parkinson disease: from research setting to clinical practice.
Politis M
Nat Rev Neurol; 2014 Dec; 10(12):708-22. PubMed ID: 25385334
[TBL] [Abstract][Full Text] [Related]
32. A disease-specific metabolic brain network associated with corticobasal degeneration.
Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
[TBL] [Abstract][Full Text] [Related]
33. Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.
O'Brien JT; Oertel WH; McKeith IG; Grosset DG; Walker Z; Tatsch K; Tolosa E; Sherwin PF; Grachev ID
BMJ Open; 2014 Jul; 4(7):e005122. PubMed ID: 24993764
[TBL] [Abstract][Full Text] [Related]
34. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.
Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
AJNR Am J Neuroradiol; 2015 Feb; 36(2):236-44. PubMed ID: 24924549
[TBL] [Abstract][Full Text] [Related]
35. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.
Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
AJNR Am J Neuroradiol; 2015 Feb; 36(2):229-35. PubMed ID: 24904053
[TBL] [Abstract][Full Text] [Related]
36. [Differential diagnostics of Parkinson's disease with nuclear medicine procedures].
Meyer PT; Amtage F; Hellwig S
Nervenarzt; 2014 Jun; 85(6):680-9. PubMed ID: 24821290
[TBL] [Abstract][Full Text] [Related]
37. Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study.
Menéndez-González M; Tavares F; Zeidan N; Salas-Pacheco JM; Arias-Carrión O
Front Aging Neurosci; 2014; 6():56. PubMed ID: 24744729
[TBL] [Abstract][Full Text] [Related]
38. Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy.
Suwijn SR; Berendse HW; Verschuur CV; de Bie RM; Booij J
ISRN Neurol; 2014; 2014():345132. PubMed ID: 24693450
[TBL] [Abstract][Full Text] [Related]
39. Pre- and postsynaptic dopamine SPECT in idiopathic Parkinsonian diseases: a follow-up study.
Jakobson Mo S; Linder J; Forsgren L; Holmberg H; Larsson A; Riklund K
Biomed Res Int; 2013; 2013():143532. PubMed ID: 24163811
[TBL] [Abstract][Full Text] [Related]
40. Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.
Bouwmans AE; Vlaar AM; Mess WH; Kessels A; Weber WE
BMJ Open; 2013; 3(4):. PubMed ID: 23550093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
